Quick reference comparing Cagrilintide with three other research peptides in our lyophilized catalog by primary mechanism, research application, and vial format
COVID-19 had only been officially declared a pandemic towards the start of that month
GLP-3 + Cagrilintide research peptide blend is not approved for human consumption, medical use, or therapeutic application
In paired designs the two peptides can be applied together or in time-resolved sequence to dissociate angiogenic (BPC-157-led) from cell-migration (TB-500-led) activity in one shared assay
If you have questions, need dosage adjustments, or would like personalized support, simply reply to this email or reach out to our team
Many BPC-157 products continue to be sold as dietary supplements through a separate regulatory pathway